Molecular identification of ERα-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes

Journal of Cellular Physiology

Volumn 200, Issue 3, 2004, Pages 440-450

  Weisz, Alessandro ^a   Basile, Walter ^a   Scafoglio, Claudio ^a   Altucci, Lucia ^a   Bresciani, Francesco ^a   Facchiano, Angelo ^b   Sismondi, Piero ^c   Cicatiello, Luigi ^a   De Bortoli, Michele ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL STRAIN MCF 7; COMPUTER MODEL; DNA MICROARRAY; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; BIOPSY; BREAST TUMOR; CLUSTER ANALYSIS; DRUG EFFECT; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REGULATOR GENE; TUMOR CELL LINE;

MINK CELL FOCUS-FORMING VIRUS;

BIOPSY; BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; EXPRESSED SEQUENCE TAGS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REGULATOR; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN;

EID: 3442875827     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20039     Document Type: Article

References (38)

1. Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D, Houlgatte R. 2002. Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum Mol Genet 11:863-872.
2. Biswas DK, Averboukh L, Sheng S, Martin K, Ewaniuk DS, Jawde TF, Wang F, Pardee AB. 1998. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Mol Med 4:454-467.
3. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE, Venter DJ. 2002. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62:1298-1295.
4. Cavailles V, Gompel A, Portois MC, Thenot S, Mabon N, Vignon F. 2002. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells. J Mol Endocrinol 28:165-175.
5. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM. 2000. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 60:5977-5983.
6. Cicatiello L, Facchiano A, Caligero R, De Bortoli M, Bresciani F, Weisz A. 2001. Gene expression monitoring in hormone-responsive human breast cancer cells during estrogen-induced cell cycle progression. Proceedings of the AACR/Nature Genetics Joint Conference: Oncogenomics: Dissecting Cancer through Genome Research. p 95. (http:// www.nature.com/cgi-taf/DynaPage.taff?file=/ng/ journal/v27/n4s/full/ ng0401supp_95a.html&_UserReference= C0AS04EC4650B9B7E02-E44E479153BOD3D72).
7. Dressman MA, Walz TM, Lavedan C, Barnes L, Buchholtz S, Kwon I, Ellis MJ, Polymeropoulos MH. 2001. Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies. Pharmacogenomics J 1:135-141.
8. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
9. Ferguson AT, Lapidus RG, Davidson NE. 1998. The regulation of estrogen receptor expression and function in human breast cancer. Cancer Treat Res 94:255-278.
10. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. 2002. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84.
11. Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, der CJ, Tamanoi F, Andres DA, Perou CM. 2001. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem 276:42259-42267.
12. Frasor J, Danes JM, Komm B, Chang KCN, Lyttle CR, Katzenellenbogen BS. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574.
13. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS. 2001. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979-5984.
14. Harris JR, Lippman ME, Morrow M, Osborne CK. 2000. Diseases of the breast. Philadelphia: Lippincott, Williams & Wilkins.
15. Hoch RV, Thompson DA, Baker RJ, Weigel RJ. 1999. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84:122-128.
16. Hopp TA, Fuqua SA. 1998. Estrogen receptor variants. J Mammary Gland Biol Neoplasia 3:73-83.
17. Ince TA, Weinberg RA. 2002. Functional genomics and the breast cancer problem. Cancer Cell 1:15-17.
18. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S. 2002. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29:175-192.
19. Liu Y, el-Ashry D, Chen D, Ding IY, Kern FG. 1995. MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo. Breast Cancer Res Treat 34:97-117.
20. Lønning PE, Sørlie T, Perou CM, Brown PO, Botstein D, Børresen-Dale A-L. 2001. Microarrays in primary breast cancer-lessons from chemotherapy studies. Endocr Relat Cancer 8:259-263.
21. Martin KJ, Kritzman BM, Price LM, Koh B, Kwan CP, Zhang X, Mackay A, O'Hare MJ, Kaelin CM, Mutter GL, Pardee AB, Sager R. 2000. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res 60:2232-2238.
22. May FE, Westley BR. 1997. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J Pathol 182:404-413.
23. Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D. 2001. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol 15:1344-1359.
24. Perissi V, Menini N, Cottone E, Capello D, Sacco M, Montaldo F, De Bortoli M. 2000. AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen. Oncogene 19:280-288.
25. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D. 1999. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96:9212-9217.
26. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale A-L, Brown PO, Botstein D. 2000. Molecular portraits of human breast tumours. Nature 406:747-752.
27. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ. 1995. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2446.
28. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. 2000. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24:227-235.
29. Seth P, Krop I, Porter D, Polyak K. 2002. Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene 21:836-843.
30. Sheikh MS, Shao ZM, Chen JC, Fontana JA. 1993. Differential regulation of matrix Gla protein (MGP) gene expression by retinoic acid and estrogen in human breast carcinoma cells. Mol Cell Endocrinol 92:153-160.
31. Sorbello V, Fuso L, Sfiligoi C, Scafoglio C, Ponzone R, Biglia N, Weisz A, Sismondi P, De Bortoli M. 2003. Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer. Int J Biol Markers 18:123-129.
32. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lønning P, Børresen-Dale A-L. 2001. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874.
33. Tang CK, Perez C, Grunt T, Waibel C, Cho C, Lupu R. 1996. Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells. Cancer Res 56:3350-3358.
34. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. 2002. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009.
35. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
36. Weisz A, Cicatiello L, Bresciani F. 1999. Microarray-based gene expression monitoring of hormone-responsive human breast cancer cells during estrogen-induced G1 progression. Proceedings of the EMBO Workshop 'Structure and Function of Nuclear Receptors'. p 60.
37. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR. 2001. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98:11462-11467.
38. Yoo JY, Lessor T, Hamburger AW. 1998. Inhibition of cell proliferation by 17beta-estradiol and heregulin beta1 in estrogen receptor negative human breast carcinoma cell lines. Breast Cancer Res Treat 51:71-81.